Once Daily Pregabalin CR Improves Therapeutic Response in Patients with Fibromyalgia
Once daily controlled-release pregabalin significantly improved time to loss of therapeutic response vs. placebo in patients with fibromyalgia, a study presented at the 2013 ACR/ARHP Annual Meeting concluded.